RaySearch Laboratories AB (publ) announces that Seoul National University Hospital (SNUH) in South Korea placed an order for the RayStation®* treatment planning system.
STOCKHOLM, April 6, 2022 /PRNewswire/ — SNUH’s Carbon Ion Center has ordered RaySearch’s RayStation Treatment Planning System for use with its Toshiba Heavy Ion Therapy System. The software includes state-of-the-art technology such as radiobiological optimization of carbon pencil beam plans and the full suite of features for dose accumulation and adaptive replanning.
Carbon ion therapy is a very advanced radiation therapy technique that can be effective for complex tumors that are difficult to treat with conventional methods. SNUH is the second carbon ion center in Korea to select RaySearch, the first customer was Yonsei Cancer Center in Seoul.
Johan Löf, Founder and CEO of RaySearch, said, “I am delighted to welcome SNUH to our growing user community. With the order from SNUH, RaySearch once again confirms our leading position in this unique segment with a worldwide market share close to 100%. .”
About Seoul National University Hospital
SNUH was founded in 1885 and for the past 130 years, this national hospital has led the advancement of medicine in Korea. The SNU Cancer Hospital opened in March 2011 and consists of 28 specialized centers.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions to improve cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the RayCare®* oncology information system (OIS). The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) that enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 800 clinics in over 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in stockholm and the stock has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®* is a flexible and innovative treatment planning system chosen by many leading cancer centers around the world. It combines unique features such as unparalleled adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for optimizing treatment plans for HDR brachytherapy and external beam therapy with photons, electrons and protons , as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing a control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also integrates seamlessly with RayCare®*. By harmonizing treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory approval in certain markets.
For more information please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8 510 530 00, [email protected]
Björn Hårdemark, Acting Chief Financial Officer, RaySearch Laboratories AB (publ)
Tel: +46 (0))709 564 217, [email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
SOURCE RaySearch Laboratories